Literature DB >> 26309892

Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for neovascular age-related macular degeneration.

Cihan Ünlü1, Gurkan Erdogan1, Betul Onal Gunay1, Betul Ilkay Sezgin Akcay1, Esra Kardes1.   

Abstract

Entities:  

Year:  2015        PMID： 26309892      PMCID： PMC4539626          DOI： 10.3980/j.issn.2222-3959.2015.04.38

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  20 in total

1.  Reduced foveolar choroidal blood flow in eyes with increasing AMD severity.

Authors:  Juan E Grunwald; Tatyana I Metelitsina; Joan C Dupont; Gui-Shuang Ying; Maureen G Maguire
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-03       Impact factor: 4.799

2.  Choroidal thickness in healthy Japanese subjects.

Authors:  Yasushi Ikuno; Kana Kawaguchi; Takeyoshi Nouchi; Yoshiaki Yasuno
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

3.  Choroidal filling in age-related macular degeneration: indocyanine green angiographic findings.

Authors:  A Giovannini; C Mariotti; E Ripa; B Scassellati Sforzolini; R Tittarelli
Journal:  Ophthalmologica       Date:  1994       Impact factor: 3.250

4.  Retinal and choroidal thickness in early age-related macular degeneration.

Authors:  Ashley Wood; Alison Binns; Tom Margrain; Wolfgang Drexler; Boris Považay; Marieh Esmaeelpour; Nik Sheen
Journal:  Am J Ophthalmol       Date:  2011-12       Impact factor: 5.258

5.  Effect of aging on foveolar choroidal circulation.

Authors:  J E Grunwald; S M Hariprasad; J DuPont
Journal:  Arch Ophthalmol       Date:  1998-02

6.  Enhanced depth imaging of the choroid in patients with neovascular age-related macular degeneration treated with anti-VEGF therapy versus untreated patients.

Authors:  Waheeda Rahman; Fred Kuanfu Chen; Jonathan Yeoh; Lyndon da Cruz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-17       Impact factor: 3.117

7.  Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.

Authors:  Taizo Yamazaki; Hideki Koizumi; Tetsuya Yamagishi; Shigeru Kinoshita
Journal:  Ophthalmology       Date:  2012-05-01       Impact factor: 12.079

8.  Intravitreal bevacizumab injection for central serous chorioretinopathy.

Authors:  Su Jin Lim; Mi In Roh; Oh Woong Kwon
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

Review 9.  A systematic review on the effect of bevacizumab in exudative age-related macular degeneration.

Authors:  Jan S A G Schouten; Ellen C La Heij; Carroll A B Webers; Igor J Lundqvist; Fred Hendrikse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-09       Impact factor: 3.117

Review 10.  Current anti-vascular endothelial growth factor dosing regimens: benefits and burden.

Authors:  Julia A Haller
Journal:  Ophthalmology       Date:  2013-05       Impact factor: 12.079
View more
  2 in total

1.  Repeatability of Choroidal Thickness Measurements on Enhanced Depth Imaging Optical Coherence Tomography Using Different Posterior Boundaries.

Authors:  Vivian S Vuong; Elad Moisseiev; David Cunefare; Sina Farsiu; Ala Moshiri; Glenn Yiu
Journal:  Am J Ophthalmol       Date:  2016-06-23       Impact factor: 5.258

2.  Macular Fluid Reduces Reproducibility of Choroidal Thickness Measurements on Enhanced Depth Optical Coherence Tomography.

Authors:  Sophia S Wong; Vivian S Vuong; David Cunefare; Sina Farsiu; Ala Moshiri; Glenn Yiu
Journal:  Am J Ophthalmol       Date:  2017-10-14       Impact factor: 5.488
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.